Get started
Author

Giuseppe Aprile

Observed name: Aprile G
ORCID: 0000-0001-9640-0030
Observed ORCID: 0000-0001-9640-0030
OpenAlex ID: A5084173043
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al. · Clinical Cancer Research · 6
PDF
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer
2025 · Alessio Carbone, Martino Oliva, et al. · JNCI Journal of the National Cancer Institute · 2
Supplementary Table S3 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Figure S2 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
PDF
Supplementary Table S2 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Figure S4 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
PDF
Supplementary Figure S1 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Figure S3 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Figure S5 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Table S4 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Data from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Supplementary Table S1 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025 · Harriet Johansson, Debora Macis, et al.
Efficacy and Safety of Pertuzumab in Metastatic Breast Cancer Patients in a Real-World Setting: Results from the SUPER-GONO (Gruppo Oncologico Del Nord Ovest) Study
2021 · Garrone O, Giarratano T, et al. · Clinics of Oncology
Works count: 13
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type